Revenue for the quarter increased 15.6% year over year to $2.26 billion while expenses grew by 23.3% to $2.39 billion, according to financial documents published Dec. 13.
Net loss for the three-month period, the fourth quarter of fiscal year 2024, was $33.2 million, down from a $239.2 million net income in the same quarter in 2023.
For the fiscal year ending Sept 30, Beth Israel Lahey reported a $248.9 million operating loss (-2.8% margin), down from a $131.2 million operating loss (-1.7% margin) in FY 2023.
As of Sept. 30, long-term debt for the health system was $1.98 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
